Rhinomed News

Chris Froome Appointed Ambassador

22013 TOUR DE FRANCE YELLOW JERSEY WINNER CHRIS FROOME APPOINTED TURBINE AMBASSADOR   6th July, 2015. Melbourne, Australia.   Rhinomed Ltd (ASX:RNO) an Australian company focused on the development of novel nasal and respiratory technology today announced 2013 Tour de France Yellow Jersey winner Chris Froome has joined as its new Turbine™ Global Ambassador.   Froome, … Read more

Can you avoid Dementia by sleeping better?

All too rarely nowadays do you come across a true epiphany. That real ‘ah ha’ moment. The exposure of a truth so startling, that the implications fundamentally change the way we see a subject. Forever. In October last year I had that experience while watching a TED talk by Assistant Professor Jeff Illif from Oregon Health and Science University … Read more

We’ve found a really good way to stay awake. Sleep.

Yes, sleep. Surprised? You shouldn’t be. It’s something we all love, something we all need and something we don’t get enough of. In fact, a lack of sleep can seriously affect your health and your ability to perform in every day life. How many times have you felt yourself beginning to drift off to sleep … Read more

RHINOMED’S MUTE™ SUCCESSFUL IN DEMONSTRATING EFFICACY AND BENEFIT IN SNORING TRIAL

RHINOMED’S MUTE™ SUCCESSFUL IN DEMONSTRATING EFFICACY AND BENEFIT IN SNORING TRIAL 2 December 2014 Melbourne technology firm, Rhinomed (ASX:RNO) today announced the topline results from its independent trial in snoring, sleep quality and night time nasal congestion which successfully demonstrated significant benefit of its new Mute nasal technology. The Company has submitted applications to the … Read more

MUTE RECEIVES MAJOR REGULATORY APPROVALS

MUTE RECEIVES MAJOR REGULATORY APPROVALS 3 December 2014 Melbourne technology firm, Rhinomed (ASX:RNO) is pleased to announce that it has successfully completed the testing and technical documentation that has enabled its new novel snoring and sleep quality product – Mute™ to gain acceptance with the US Food and Drug Administration(FDA), European authority (CE Mark) and … Read more

RHINOMED RELEASES MUTE SLEEP TECHNOLOGY

RHINOMED RELEASES MUTE SLEEP TECHNOLOGY 8 December 2014 Melbourne bio-technology firm, Rhinomed (ASX:RNO) is pleased to announce the release of its newest device from it nasal respiratory technology stable of products, Mute™, a nasal breathing aid to alleviate snoring and improve sleep quality. Mute™ was successfully registered last week with the US FDA, Australian TGA and given permission to use the CE Mark … Read more